On Friday, VolitionRX Ltd (AMEX: VNRX) opened lower -4.26% from the last session, before settling in for the closing price of $0.27. Price fluctuations for VNRX have ranged from $0.23 to $0.94 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.38%. Company’s average yearly earnings per share was noted 31.34% at the time writing. With a float of $97.40 million, this company’s outstanding shares have now reached $109.62 million.
VolitionRX Ltd (VNRX) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of VolitionRX Ltd is 20.69%, while institutional ownership is 21.27%. The most recent insider transaction that took place on Nov 17 ’25, was worth 7,000. In this transaction President and CEO of this company bought 20,000 shares at a rate of $0.35, taking the stock ownership to the 2,554,847 shares. Before that another transaction happened on Oct 14 ’25, when Company’s President and CEO bought 110,000 for $0.51, making the entire transaction worth $56,100. This insider now owns 2,534,847 shares in total.
VolitionRX Ltd (VNRX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.06 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.05) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.34% per share during the next fiscal year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
Check out the current performance indicators for VolitionRX Ltd (VNRX). In the past quarter, the stock posted a quick ratio of 0.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 21.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of VolitionRX Ltd (VNRX)
Looking closely at VolitionRX Ltd (AMEX: VNRX), its last 5-days average volume was 3.81 million, which is a jump from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 35.33%.
During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 4.31%, which indicates a significant decrease from 21.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0269 in the past 14 days, which was lower than the 0.0403 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3620, while its 200-day Moving Average is $0.5441. However, in the short run, VolitionRX Ltd’s stock first resistance to watch stands at $0.2654. Second resistance stands at $0.2747. The third major resistance level sits at $0.2817. If the price goes on to break the first support level at $0.2491, it is likely to go to the next support level at $0.2421. Should the price break the second support level, the third support level stands at $0.2328.
VolitionRX Ltd (AMEX: VNRX) Key Stats
There are currently 122,802K shares outstanding in the company with a market cap of 31.44 million. Presently, the company’s annual sales total 1,230 K according to its annual income of -26,970 K. Last quarter, the company’s sales amounted to 630 K and its income totaled -5,380 K.
